Fox Run Management L.L.C. Buys New Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Fox Run Management L.L.C. purchased a new position in ICU Medical, Inc. (NASDAQ:ICUI) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 4,591 shares of the medical instruments supplier’s stock, valued at approximately $712,000.

Several other hedge funds have also bought and sold shares of ICUI. Barclays PLC increased its holdings in shares of ICU Medical by 15.6% in the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock worth $10,790,000 after purchasing an additional 8,010 shares during the last quarter. Principal Financial Group Inc. grew its holdings in ICU Medical by 24.6% during the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock valued at $23,130,000 after buying an additional 25,031 shares in the last quarter. MetLife Investment Management LLC increased its stake in ICU Medical by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 12,389 shares of the medical instruments supplier’s stock worth $2,258,000 after acquiring an additional 6,981 shares during the last quarter. Jennison Associates LLC purchased a new stake in shares of ICU Medical during the 4th quarter worth approximately $556,000. Finally, Geode Capital Management LLC boosted its position in shares of ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after acquiring an additional 48,106 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the completion of the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. The trade was a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 6.70% of the company’s stock.

ICU Medical Stock Performance

NASDAQ ICUI opened at $147.07 on Monday. The business’s 50 day moving average price is $156.08 and its 200-day moving average price is $164.43. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26. The company has a market cap of $3.61 billion, a P/E ratio of -32.18 and a beta of 0.73. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Analysts Set New Price Targets

ICUI has been the subject of a number of recent research reports. Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price for the company in a report on Wednesday, December 11th. Raymond James set a $97.00 price objective on shares of ICU Medical in a research note on Wednesday, March 12th. Finally, StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, March 18th. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, ICU Medical has a consensus rating of “Buy” and an average price target of $168.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.